Рекомендации ESPEN-ESPGHAN-ECFS по диетотерапии при муковисцидозе у младенцев, детей и взрослых

Gronowitz E, Garemo M, Lindblad A, Mellstrom D, Strandvik B. Decreased [221 bone mineral density in normal-growing patients with cystic fibrosis. Acta Paediatr 2003;92:688-93

184

Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W. Cystic fibrosis- related diabetes: current trends in prevalence, incidence, and mortality. [223 Diabetes Care 2009;32:1626-31

185

Moran A, Pillay K, Becker DJ, Acerini CL. Management of cystic fibrosis. [224 related diabetes in children and adolescents. Pediatr Diabetes 2014; 15 (Suppl. 20):65-76

186

Moran A, Brunzell C, Cohen RC, Katz M, Marshall ВС, Onady G, et al. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of [225 the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care 2010;33:2697-708

187

Moran A, Brunzell C, Cohen RC, Katz M, Marshall ВС, Onady G, et al. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of [225 the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care 2010;33:2697-708

188

Colombo C, Battezzati PM, Crosignani A, Morabito A, Costantini D, Padoan R, et al. Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome. Hepatology 2002;36:1374-82

189

Van Biervliet S, Van Biervliet JP, Robberecht E, Christophe A. Fatty acid composition of serum phospholipids in cystic fibrosis (CF) patients with or without CF related liver disease. Clin Chem Lab Med 2010;48:1751-5

190

Colombo C, Costantini D, Rocchi A, Romano G, Rossi G, Bianchi ML, et al. Effects of liver transplantation on the nutritional status of patients with cystic fibrosis. Transpl Int 2005;18:246-55

191

Maqbool A, Schall JI, Garcia-Espana JF, Zemel BS, Strandvik B, Stallings VA. Serum linoleic acid status as a clinical indicator of essential fatty acid status in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 2008;47: 635-44

192

Christophe A, Robberecht E. Current knowledge on fatty acids in cystic fibrosis. Prostagl Leukot Essent Fat Acids 1996;55:129-38

193

Coste TC, Armand M, Lebacq J, Lebecque P, Wallemacq P, Leal T. An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis. [234 Clin Biochem 2007;40:511-20

194

Lloyd-Still JD, Bibus DM, Powers CA, Johnson SB, Holman RT. Essential fatty acid deficiency and predisposition to lung disease in cystic fibrosis. ActaPaediatr 1996;85:1426-32

195

Walkowiak J, LisowskaA, Blaszczynski M, Przyslawski J, Walczak M. Poly-unsaturated fatty acids in cystic fibrosis are related to nutrition and clinical expression of the disease. J Pediatr Gastroenterol Nutr 2007;45:488-9. author reply 489

196

Jorgensen MH, Ott P, Michaelsen KF, Porsgaard T, Jensen F, Lanng S. Long- chain PUFA in granulocytes, mononuclear cells, and RBC in patients with [236 cystic fibrosis: relation to liver disease. J Pediatr Gastroenterol Nutr 2012;55:76-81

197

Freedman SD, Blanco PG, Zaman MM, Shea JC, Ollero M, Hopper IK, et al. [230 Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med 2004;350:560-9

198

Lloyd-Still JD, Bibus DM, Powers CA, Johnson SB, Holman RT. Essential fatty acid deficiency and predisposition to lung disease in cystic fibrosis. ActaPaediatr 1996;85:1426-32

199

Walkowiak J, LisowskaA, Blaszczynski M, Przyslawski J, Walczak M. Poly-unsaturated fatty acids in cystic fibrosis are related to nutrition and clinical expression of the disease. J Pediatr Gastroenterol Nutr 2007;45:488-9. author reply 489

200

Gronowitz E, Lorentzon M, Ohlsson C, Mellstrom D, Strandvik B. Docosa-hexaenoic acid is associated with endosteal circumference in long bones in [219 young males with cystic fibrosis. Br J Nutr 2008;99:160-7

201

Gronowitz E, Mellstrom D, Strandvik B. Serum phospholipid fatty acid pattern is associated with bone mineral density in children, but not adults, with cystic fibrosis. Br J Nutr 2006;95:1159-65

202

Njoroge SW, Seegmiller AC, Katrangi W, Laposata M. Increased Delta5- and [237 Delta6-desaturase, cyclooxygenase-2, and lipoxygenase-5 expression and activity are associated with fatty acid and eicosanoid changes in cystic fibrosis. Biochim Biophys Acta 2011;1811:431-40

203

Jorgensen MH, Ott P, Michaelsen KF, Porsgaard T, Jensen F, Lanng S. Long- chain PUFA in granulocytes, mononuclear cells, and RBC in patients with [236 cystic fibrosis: relation to liver disease. J Pediatr Gastroenterol Nutr 2012;55:76-81

204

Panchaud A, Sauty A, Kernen Y, Decosterd LA, Buclin T, Boulat O, et al. Biological effects of a dietary omega-3 polyunsaturated fatty acids supplementation in cystic fibrosis patients: a randomized, crossover placebo-controlled trial. Clin Nutr 2006;25:418-27

205

Strandvik B, Berg U, Kallner A, Kusoffsky E. Effect on renal function of essential fatty acid supplementation in cystic fibrosis. J Pediatr 1989;115: 242-50

206

Maqbool A, Schall JI, Garcia-Espana JF, Zemel BS, Strandvik B, Stallings VA. Serum linoleic acid status as a clinical indicator of essential fatty acid status in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 2008;47: 635-44

207

Coste TC, Armand M, Lebacq J, Lebecque P, Wallemacq P, Leal T. An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis. [234 Clin Biochem 2007;40:511-20

208